Urena P - Search Results

1

Yajima A, Tsuchiya K, Kuro-O M, Urena P, Tominaga Y, Okada M, Ichimori T, Tomosugi T, Hiramitsu T, Murata T, Nakamura M, Sasaki M, Ito A, Nitta K. Yajima A, et al. Among authors: urena p. Vitam Horm. 2022;120:305-343. doi: 10.1016/bs.vh.2022.04.010. Epub 2022 Jul 22. Vitam Horm. 2022. PMID: 35953115

2

[Cinacalcet treatment for secondary hyperparathyroidism in dialysis patients in real-world clinical practice - the ECHO observational study: French experience].

Ureña P, Fouque D, Brunet P, Touam M, Réglier JC. Ureña P, et al. Nephrol Ther. 2012 Dec;8(7):527-33. doi: 10.1016/j.nephro.2012.05.002. Epub 2012 Sep 25. Nephrol Ther. 2012. PMID: 23018042 French.

3

Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.

Bover J, Ureña P, Ruiz-García C, daSilva I, Lescano P, del Carpio J, Ballarín J, Cozzolino M. Bover J, et al. Among authors: urena p. Clin J Am Soc Nephrol. 2016 Jan 7;11(1):161-74. doi: 10.2215/CJN.01760215. Epub 2015 Jul 29. Clin J Am Soc Nephrol. 2016. PMID: 26224878 Free PMC article. Review.

4

Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.

Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S, Rix M, Os I, Saha H, Ryba M, Bencova V, Baños A, Zani V, Fouque D. Ureña P, et al. Nephrol Dial Transplant. 2009 Sep;24(9):2852-9. doi: 10.1093/ndt/gfp144. Epub 2009 Apr 15. Nephrol Dial Transplant. 2009. PMID: 19369690

5

Use of calcimimetics in uremic patients with secondary hyperparathyroidism: review.

Ureña P. Ureña P. Artif Organs. 2003 Sep;27(9):759-64. doi: 10.1046/j.1525-1594.2003.07262.x. Artif Organs. 2003. PMID: 12940896 Review.

6

Adynamic bone disease: from bone to vessels in chronic kidney disease.

Bover J, Ureña P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I, Bosch RJ. Bover J, et al. Among authors: urena p. Semin Nephrol. 2014 Nov;34(6):626-40. doi: 10.1016/j.semnephrol.2014.09.008. Semin Nephrol. 2014. PMID: 25498381 Review.

7

Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease.

Bover J, Arana C, Ureña P, Torres A, Martín-Malo A, Fayos L, Coll V, Lloret MJ, Ochoa J, Almadén Y, Guirado L, Rodríguez M. Bover J, et al. Among authors: urena p. Nefrologia (Engl Ed). 2021 Sep-Oct;41(5):514-528. doi: 10.1016/j.nefroe.2021.11.014. Epub 2021 Dec 14. Nefrologia (Engl Ed). 2021. PMID: 36165134 Free article. Review.

8

[Contributions of the software La Clé Concerto in the implementation of the NKF-K/DOQI (National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative) recommendations for the control of mineral and bone metabolism disorders in the patient with chronic renal failure].

Ureña P. Ureña P. Nephrol Ther. 2008 Sep;4 Spec No 1:9-14, 20-35. Nephrol Ther. 2008. PMID: 19031633 French. No abstract available.

9

Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.

Hruby M, Ureña P, Mannstadt M, Schmitt F, Lacour B, Drüeke TB. Hruby M, et al. Among authors: urena p. Nephrol Dial Transplant. 1996 Sep;11(9):1781-6. Nephrol Dial Transplant. 1996. PMID: 8918622

10

Effect of 22-oxa-calcitriol on calcium metabolism in rats with severe secondary hyperparathyroidism.

Kubrusly M, Gagné ER, Ureña P, Hanrotel C, Chabanis S, Lacour B, Drüeke TB. Kubrusly M, et al. Among authors: urena p. Kidney Int. 1993 Sep;44(3):551-6. doi: 10.1038/ki.1993.280. Kidney Int. 1993. PMID: 8231027 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page